Sequana medical NV 

€0.44
44
+€0.05+12.9% Thursday 07:47

Statistics

Day High
0.41
Day Low
0.41
52W High
1.58
52W Low
0.37
Volume
-
Avg. Volume
-
Mkt Cap
25.29M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30MarExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Next
-0.73
-0.49
-0.24
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-42,526.67%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
210,000Revenue
-89.31MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2SE.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc offers medical technologies, services, and solutions, including those for fluid management, competing in similar markets as Sequana Medical.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, overlapping with Sequana Medical's focus areas.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, including fluid management devices.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a portfolio of healthcare products, including renal and hospital products, competing in the fluid management space.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the healthcare field, offering products and devices in various segments including surgery, orthopaedics, and cardiovascular health, which may overlap with Sequana's offerings.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences Corporation specializes in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring, areas that can compete with Sequana's medical devices.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; and surgical products, including devices for fluid management.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical and surgical equipment and neurotechnology and spine products, potentially competing in the same healthcare solutions as Sequana Medical.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products which could compete in the women's health sector, overlapping with some of Sequana's target markets.

About

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
Show more...
CEO
Mr. Ian Crosbie
Employees
48
Country
BE
ISIN
BE0974340722
WKN
000A2PD78

Listings

0 Comments

Share your thoughts

FAQ

What is Sequana medical NV stock price today?
The current price of 2SE.F is €0.44 EUR — it has increased by +12.9% in the past 24 hours. Watch Sequana medical NV stock price performance more closely on the chart.
What is Sequana medical NV stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sequana medical NV stocks are traded under the ticker 2SE.F.
Is Sequana medical NV stock price growing?
2SE.F stock has risen by +9.54% compared to the previous week, the month change is a -25.08% fall, over the last year Sequana medical NV has showed a -51.11% decrease.
What is Sequana medical NV market cap?
Today Sequana medical NV has the market capitalization of 25.29M
When is the next Sequana medical NV earnings date?
Sequana medical NV is going to release the next earnings report on September 03, 2026.
What is Sequana medical NV revenue for the last year?
Sequana medical NV revenue for the last year amounts to 210,000 EUR.
What is Sequana medical NV net income for the last year?
2SE.F net income for the last year is -89.31M EUR.
How many employees does Sequana medical NV have?
As of April 05, 2026, the company has 48 employees.
In which sector is Sequana medical NV located?
Sequana medical NV operates in the Health Care sector.
When did Sequana medical NV complete a stock split?
Sequana medical NV has not had any recent stock splits.
Where is Sequana medical NV headquartered?
Sequana medical NV is headquartered in Gent, BE.